AzTrials
AzTrials

Degenerative SpineMassoud-GoelNCT07001969

Percutaneous Trans-facet Spine Fixation

A study testing Massoud-Goel Technique and Theory and Percutaneous Trans-facet Fixation for Treatment of Degenerative Spine in people with Degenerative Spine and Degeneration of Lumbar Intervertebral Disc, run by Mahmoud Massoud at 1 site in Egypt.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

Percutaneous Trans-facet Fixation Massoud-Goel Technique and Theory for Treatment of Degenerative Spine Read more about this study

Who is it for?
Any age
What is being tested?
Massoud-Goel Technique and Theory and Percutaneous Trans-facet Fixation for Treatment of Degenerative Spine
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
77 participants
Where
1 siteEgypt
Study dates
7 Jul 2024to 7 Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • For Lumbar Sub-axial cervical instability Clinical radicular symptoms can indicate the level of spinal instability. The presence of osteophytes. Reduction of the intervertebral disc space. Disc prolapse. Ligamentum flavum buckling. For atlantoaxial instability Cervical myelopathy clinical Alteration of atlantodental interval on dynamic flexion-extension images.

Who cannot join

  • Cauda equine syndrome
  • Progressive motor weakness
  • Failed damage control method
  • Spondylolisthesis, Spondyolysis.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Egypt1 site
  • 434

    Cairo, Shorouk, 41639

Other trials in Egypt

About this study

Official title: Massoud-Goel Technique and Theory: Percutaneous Trans-facet Fixation for Treatment of Degenerative Spine

Percutaneous Trans-facet Fixation Massoud-Goel Technique and Theory for Treatment of Degenerative Spine

Read the detailed description

Massoud-Goel' as rationale treatment for treatment spinal degeneration affected spinal segments using trans-articular screws, without physically distracting the facets, or removal of any part of the bone or ligament.

Following fixing of the segment, all the secondary phenomenon reverse, effectively increasing the canal size and reversing the effects of spinal degeneration and spinal canal stenosis.

Stabilizes the region and provides an environment for resorption of the herniated disc and ultimate arthrodesis of the spinal segments.

Being tested
Massoud-Goel Technique and Theory, Percutaneous Trans-facet Fixation for Treatment of Degenerative Spine
Keywords
Percutaneous, Trans-facet, Fixation, Massoud-Goel, Technique and Theory for Treatment of Degenerative Spine
Medical subject headings
Spinal Stenosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Massoud-Goel Technique and TheoryProcedure or surgery

    Percutaneous Trans-facet Fixation Massoud-Goel Technique and Theory for Treatment of Degenerative Spine

  • Percutaneous Trans-facet Fixation for Treatment of Degenerative SpineProcedure or surgery

    Percutaneous Trans-facet Fixation (Developmental of Dr Atul goel technique of transfacet fixation by open surgery using Magrel technique) Massoud-Goel Technique and Theory for Treatment of Degenerative Spine

Study groups in NCT07001969
Study groupRoleWhat they receive
Percutaneous Trans-Facet Fixation Using the Massoud-Goel Technique and Theory for Degenerative SpineExperimentalThis study arm involves the use of Percutaneous Trans-Facet Fixation (PTFF) with the Massoud-Goel Technique and Theory (MGT) for the treatment of degenerative spine conditions, Looking for signs of instability. In this arm will undergo minimally invasive trans-facet screw fixation to provide spinal stability while preserving mobility and reducing soft tissue disruption. The intervention includes: * Preoperative Assessment: MRI and CT scans to evaluate facet joint degeneration and spinal instability. * Surgical Technique: Percutaneous placement of facet screws under fluoroscopic guidance, following the principles of the Massoud-Goel Technique. * Postoperative Care: Patients will follow a structured rehabilitation program, including pain management and physiotherapy, to assess functional recovery and long-term outcomes. The study aims to evaluate radiological fusion rates, pain relief (VAS scores), functional improvement (ODI scores), and complication rates associations.
Receives: Procedure: Massoud-Goel Technique and Theory; Procedure: Percutaneous Trans-facet Fixation for Treatment of Degenerative Spine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain relief

    Relief of pain from neuralgia (sciatica \& brachialgia) also claudication pain assessment by visual analogue scale 1-10

    Measured: 3 months

Secondary outcomes (4)
  1. Functional recovery

    functional improvement postoperatively. Secondary outcomes include functional recovery (Oswestry Disability Index score)

    Measured: 3 months

  2. Less complications

    fusion rates (CT scan), and complication rates, assessing both efficacy and safety.

    Additional measures like hospital stay duration and patient satisfaction provide insights into procedural efficiency and patient-reported outcomes.

    Measured: 1 year

  3. Spinal stability

    By CT spine we can assess facet fusion, stabilization of spine segmental instability

    Measured: 6 months

  4. Neurological decompression indirectly

    Early by position of patients intraoperative and stabilization, late by healing of pathological state of ligament flavum hypertrophic changes, disc degeneration, spinal canal stenosis by Magnetic resonance imaging follow-up

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2025
  2. Study start7 Jul 2024
  3. Primary completion7 Feb 2025
  4. Study completion7 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
77 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07001969
Sponsor's protocol ID
EGY-2025-PTFF-MGT-001
Acronym
Massoud-Goel
Status last verified
May 2025
First submitted
13 Feb 2025
Last updated
3 Jun 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: New researches

Publications

  • Borm W, Konig RW, Albrecht A, Richter HP, Kast E. Percutaneous transarticular atlantoaxial screw fixation using a cannulated screw system and image guidance. Minim Invasive Neurosurg. 2004 Apr;47(2):111-4. doi: 10.1055/s-2004-818449.

    PubMed 15257485
  • Magerl FP. Stabilization of the lower thoracic and lumbar spine with external skeletal fixation. Clin Orthop Relat Res. 1984 Oct;(189):125-41.

    PubMed 6478690
  • BOUCHER HH. A method of spinal fusion. J Bone Joint Surg Br. 1959 May;41-B(2):248-59. doi: 10.1302/0301-620X.41B2.248. No abstract available.

    PubMed 13641310
  • KING D. Internal fixation for lumbosacral fusion. J Bone Joint Surg Am. 1948 Jul;30A(3):560-5. No abstract available.

    PubMed 18109577
  • Goel A. Goel's classification of atlantoaxial "facetal" dislocation. J Craniovertebr Junction Spine. 2014 Jan;5(1):3-8. doi: 10.4103/0974-8237.135206. No abstract available.

    PubMed 25013340
  • Satoskar SR, Goel AA, Mehta PH, Goel A. Quantitative morphometric analysis of the lumbar vertebral facets and evaluation of feasibility of lumbar spinal nerve root and spinal canal decompression using the Goel intraarticular facetal spacer distraction technique: A lumbar/cervical facet comparison. J Craniovertebr Junction Spine. 2014 Oct;5(4):157-62. doi: 10.4103/0974-8237.147079.

    PubMed 25558146
  • Goel A. From "only decompression" to "only fixation:" A century-long journey of surgical treatment for spinal spondylosis. J Craniovertebr Junction Spine. 2018 Oct-Dec;9(4):219-220. doi: 10.4103/jcvjs.JCVJS_118_18. No abstract available.

    PubMed 30783342

Questions about this trial

What is this clinical trial studying?

A study testing Massoud-Goel Technique and Theory and Percutaneous Trans-facet Fixation for Treatment of Degenerative Spine in people with Degenerative Spine and Degeneration of Lumbar Intervertebral Disc, run by Mahmoud Massoud at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 3 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain relief (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07001969, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in